0801.HK - Golden Meditech Holdings Limited

HKSE - HKSE Delayed Price. Currency in HKD
1.210
+0.030 (+2.542%)
At close: 11:59AM HKT
Stock chart is not supported by your current browser
Previous Close1.180
Open1.180
Bid1.170 x 0
Ask1.190 x 0
Day's Range1.180 - 1.220
52 Week Range1.000 - 1.400
Volume2,416,000
Avg. Volume3,150,230
Market Cap3.589B
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.050
Earnings DateN/A
Forward Dividend & Yield0.03 (1.10%)
Ex-Dividend Date2015-08-04
1y Target EstN/A
  • PR Newswire6 days ago

    Golden Meditech Declares a Special Dividend to Shareholders

    HONG KONG, Feb. 13, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China, is pleased to announce that the board of directors of the Company (the "Board") declares a special cash dividend of HK$0.30 per share in acknowledgment of the continuous support and trust from its shareholders, following the completion of the sale of equity interest in China Cord Blood Corporation. Additionally, the Company is proactively looking for investment opportunities, if there are no suitable investment projects, the Board may consider declaring further special dividend.

  • PR Newswire6 days ago

    Golden Meditech Declares a Special Dividend to Shareholders

    HONG KONG , Feb. 13, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China , is pleased to announce ...

  • PR Newswire12 days ago

    Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by its Associate, Cellenkos, Inc.

    HONG KONG, Feb. 7, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise in China, announces that its associate, Cellenkos, Inc. ("Cellenkos") successfully registered its stand-alone, manufacturing facility as good manufacturing practice ("GMP") compliant with United States Food and Drug Administration ("FDA"). Cellenkos is a clinical-stage biotechnology company focused on developing universal donor cell therapeutics derived from cord blood for the treatment of autoimmune diseases and inflammatory conditions.

  • PR Newswire12 days ago

    Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by its Associate, Cellenkos, Inc.

    HONG KONG , Feb. 7, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise in China , announces that its ...

  • PR Newswire15 days ago

    Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund

    HONG KONG, Feb. 4, 2018 /PRNewswire/ --  Golden   Meditech   Holdings   Limited ( SEHK   stock   code : 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the ...

  • PR Newswire15 days ago

    Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund

    HONG KONG, Feb. 4, 2018 /PRNewswire/ --  Golden   Meditech   Holdings   Limited ( SEHK   stock   code : 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the ...

  • PR Newswire18 days ago

    Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE

    HONG KONG , Feb. 1, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China , announces today the TDR ...

  • PR Newswire18 days ago

    Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE

    HONG KONG , Feb. 1, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China , announces today the TDR ...

  • PR Newswire19 days ago

    Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation

    HONG KONG , Jan. 31, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China , is pleased to announce ...

  • PR Newswire19 days ago

    Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation

    HONG KONG , Jan. 31, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited  (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise in China , is pleased to announce ...

  • PR Newswire3 months ago

    Golden Meditech Announces FY2017/2018 Interim Results

    Qinghe Hospital Achieves Revenue Contribution, Significant Growth in Healthcare Services Business Strategic Roadmap in the Advanced Medical Fields to Diversify the Group's Business and Revenue Stream HONG ...

  • PR Newswire3 months ago

    Golden Meditech Announces FY2017/2018 Interim Results

    Qinghe Hospital Achieves Revenue Contribution, Significant Growth in Healthcare Services Business Strategic Roadmap in the Advanced Medical Fields to Diversify the Group's Business and Revenue Stream HONG ...

  • Reuters3 months ago

    BRIEF-Golden Meditech Holdings Says HY Revenue From Cont Ops Fell 3.8 Pct

    Nov 30 (Reuters) - Golden Meditech Holdings Ltd:: * HY ‍TOTAL REVENUE FROM CONTINUING OPERATIONS HK$117.1 MILLION, DOWN 3.8 PERCENT​ * HY ‍LOSS ATTRIBUTABLE FROM CONTINUING OPERATIONS HK$287.4 MILLION ...

  • PR Newswire3 months ago

    Golden Meditech and GE Healthcare Team Up to Develop Safe and Efficient Cord Blood Storage Services

    HONG KONG , Nov. 16, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, ...

  • PR Newswire3 months ago

    Golden Meditech and GE Healthcare Team Up to Develop Safe and Efficient Cord Blood Storage Services

    HONG KONG , Nov. 16, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, ...

  • PR Newswire3 months ago

    Golden Meditech Announces Redemption of Convertible Notes

    HONG KONG , Nov. 13, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) (the "Company"), a leading integrated healthcare enterprise in China ...

  • PR Newswire3 months ago

    Golden Meditech Announces Redemption of Convertible Notes

    HONG KONG , Nov. 13 , 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) (the "Company"), a leading integrated healthcare enterprise in China ...

  • PR Newswire4 months ago

    Golden Meditech Announces the Proposed Voluntary Delisting of TDR on TWSE

    HONG KONG, Oct. 30, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, today announces that the board of directors of the Company resolved to initiate an application for the voluntary delisting (the "Voluntary Delisting") of the Taiwan depository receipts ("TDR") from the Taiwan Stock Exchange Corporation ("TWSE"), the repurchase of TDR resulting from the Voluntary Delisting and the TDR conversion offer.

  • PR Newswire4 months ago

    Golden Meditech Announces the Proposed Voluntary Delisting of TDR on TWSE

    Hong Kong, Oct. 30, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, today announces that the board of directors of the Company resolved to initiate an application for the voluntary delisting (the "Voluntary Delisting") of the Taiwan depository receipts ("TDR") from the Taiwan Stock Exchange Corporation ("TWSE"), the repurchase of TDR resulting from the Voluntary Delisting and the TDR conversion offer.

  • PR Newswire8 months ago

    Golden Meditech Announces FY2016/2017 Annual Results

    Hospital Management Business Showing Upward Trend, Sunbow O&G Hospital and Qinghe Hospital Will Be The New Growth Momentum Sales of Discontinuing Operation Will Enrich Cash Reserve, Expedite Diversified ...

  • PR Newswire8 months ago

    Golden Meditech Announces FY2016/2017 Annual Results

    Hospital Management Business Showing Upward Trend, Sunbow O&G Hospital and Qinghe Hospital Will Be The New Growth Momentum Sales of Discontinuing Operation Will Enrich Cash Reserve, Expedite Diversified ...

  • PR Newswire10 months ago

    Golden Meditech Announces the Close of the Voluntary Conditional Cash Offer and Remains Public

    HONG KONG, April 10, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") closed on 10 April 2017. As of today, valid acceptances of the cash offer have been received in respect of 968,774,034 shares (representing approximately 32.66% of the issued share capital and voting rights of the Company).

  • PR Newswire10 months ago

    Golden Meditech Announces the Close of the Voluntary Conditional Cash Offer and Remains Public

    HONG KONG, April 10, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") closed on 10 April 2017. As of today, valid acceptances of the cash offer have been received in respect of 968,774,034 shares (representing approximately 32.66% of the issued share capital and voting rights of the Company).

  • PR Newswire11 months ago

    Golden Meditech Announces the Condition to the Voluntary Conditional Cash Offer Has Been Satisfied

    HONG KONG, March 15, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the shareholding ratio condition to the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") has been satisfied, as a result, the voluntary conditional cash offer is now unconditional. As of today, valid acceptances of the cash offer have been received in respect of 460,817,868 shares (representing approximately 15.54% of the issued share capital and voting rights of the Company).

  • PR Newswire11 months ago

    Golden Meditech Announces the Condition to the Voluntary Conditional Cash Offer Has Been Satisfied

    HONG KONG, March 15, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ( "Golden Meditech" or the "Company"), a leading integrated ...